Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Profit and Loss
Beryl Drugs Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs & Formln  Chairman  : Sudhir Sethi
    Home        : Indian Private  Book Value: 18.6259045
    BSE Code  : 524606  Market Cap: 11.79
    NSE Code  :   P / E              : 50.54 

Change Company :
(Rs in Cr.)
Profit and Loss
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Sales Turnover & Other Income 22.5627.1327.1614.7614.73
Excise Duty0.000.000.000.000.00
Total Income22.9027.3026.8515.0614.76
Raw Materials 1.121.481.250.900.76
Stock Adjustments 0.340.17-0.310.300.03
Other Manufacturing Expenses 12.7515.0215.789.047.90
Power & Fuel Cost1.251.541.270.850.86
Employee Cost 2.211.931.701.311.18
Selling and Administration Expenses 2.894.644.502.161.92
Miscellaneous Expenses 0.020.000.070.210.06
Less: Preoperative Expenditure Capitalised0.000.000.000.000.00
Profit before Interest, Depreciation & Tax2.662.682.270.602.09
Interest & Financial Charges 0.540.470.470.460.47
Profit before Depreciation & Tax2.122.211.800.141.62
Depreciation1.251.200.811.091.27
Profit Before Tax0.871.010.99-0.950.35
Tax0.290.240.22-0.290.11
Profit After Tax0.580.770.77-0.660.24
Adjustment below Net Profit 0.000.000.000.000.00
P & L Balance brought forward3.773.002.232.892.65
Appropriations 0.000.000.000.000.00
P & L Bal. carried down4.353.773.002.232.89
Equity Dividend0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Corporate Dividend Tax0.000.000.000.000.00
Equity Dividend (%)0.000.000.000.000.00
Earning Per Share (Rs.)1.141.511.50-1.290.47
Book Value18.6617.5215.8414.3215.57
Extraordinary Items 0.000.010.000.000.34
Top
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter / Complaints   |   Smart ODR   |   Scores   |   Attention Investors   | Audit Compliance Report   | RA – Annual Compliance Audit Report 2024-25   | UPI IDs for Payment

SEBI Saa₹thi Mobile App/SEBI Investor Website  

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Developed & Maintained By C-MOTS Infotech(ISO 9001:2015 certified)
Content powered by Capital Market Charts are powered by TradingView